About Gary Burgess
Form D filings for Aerami Therapeutics in 2023 list Gary Burgess as chief medical officer.
Gary Burgess first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Gary Burgess in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gary Burgess works with at each company, as listed on that company's latest Form D.
Aerami Therapeutics Holdings, Inc. · Form D, Nov 22, 2023
AW
Anne Whitaker
Chief Executive Officer, Chairwoman of the Board
AS
Adam Stern
Director
JP
John Patton
Director
ST
Steven Thornton
Director
WW
William Welch
Director
JZ
Joshua Ziel
Chief Operating Officer
DH
Darlene Deptula-Hicks
Chief Financial Officer and Director